PLX Stock Earnings: Protalix BioTherapeutics Misses EPS, Misses Revenue for Q1 2024
investorplace.com/earning-results/2024/05/plx-stock-earnings-protalix-biotherapeutics-for-q1-of-2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
PLX stock results show that Protalix BioTherapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
The post PLX Stock Earnings: Protalix BioTherapeutics Misses EPS, Misses Revenue for Q1 2024 appeared first on InvestorPlace.
More From InvestorPlace
The #1…
This story appeared on investorplace.com, .